Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Pennsylvania adds 2,600 manufacturing jobs amid major investments and policy shifts.

Market News
23 Jun 2026
Fox Business
View Source
Bullish
pluang ai news

President Trump highlighted the creation of over 2,600 manufacturing jobs in Pennsylvania during a visit to the Mack Trucks facility. He credited his administration's policies, including rolling back stringent fuel emissions regulations, for boosting job growth and supporting companies like Mack Trucks. Significant investments from companies such as Eli Lilly, Nokia, and B. Braun were also noted, signaling strong growth in the region's manufacturing and technology sectors. These developments underscore Pennsylvania's role as a key battleground state with expanding industrial opportunities ahead of the midterm elections.

More News (LLY)

The 16th annual PODD conference on drug delivery innovation will be held in Boston this October.

The 16th annual PODD conference on drug delivery innovation will be held in Boston this October.

The 16th annual PODD (Partnership Opportunities in Drug Delivery) conference will take place on October 29-30, 2026, in Boston, gathering over 1,000 industry leaders to discuss advancements in drug delivery systems. The event features over 150 sessio...

Others
Bullish
13 hours ago
Illumina adds Eli Lilly's Dr. Skovronsky to board to boost genomics innovation

Illumina adds Eli Lilly's Dr. Skovronsky to board to boost genomics innovation

Illumina appointed Dr. Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly, to its Board of Directors. His expertise in drug discovery and clinical development aligns with Illumina's focus on genomics and multiomics innovation. Th...

Company Fundamentals
Bullish
16 hours ago
Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

New long-term data from the ADjoin trial shows that lebrikizumab, an injectable treatment for moderate to severe atopic dermatitis, maintains skin clearance and reduces itching for up to 2 years even with monthly dosing instead of biweekly. About 76%...

Market News
Bullish
1 day ago
Lilly's $7.8B acquisition of Centessa approved by UK High Court, closing expected June 24, 2026.

Lilly's $7.8B acquisition of Centessa approved by UK High Court, closing expected June 24, 2026.

The High Court of Justice of England and Wales has approved Eli Lilly's acquisition of Centessa Pharmaceuticals for $38 per share plus potential milestone payments, valuing the deal at about $7.8 billion. The transaction will close on June 24, 2026, ...

Company Fundamentals
Bullish
1 day ago
Eli Lilly leads obesity drug race with strong Q1 growth; Pfizer rebuilds post-COVID with new acquisitions.

Eli Lilly leads obesity drug race with strong Q1 growth; Pfizer rebuilds post-COVID with new acquisitions.

Eli Lilly reported a 55.5% revenue increase to $19.80B in Q1 2026, driven by obesity drugs Mounjaro and Zepbound, while Pfizer's revenue rose 5.4% to $14.45B, supported by Eliquis and oncology products but weighed down by declining COVID-related sale...

Company Fundamentals
Bullish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App